Your browser doesn't support javascript.
loading
The Impact of Substantial Improvements in HbA1c and Weight Loss on the Medication Preferences of People with Type 2 Diabetes.
Gelhorn, Heather L; Osumili, Beatrice; Brown, Katelyn; Ross, Melissa M; Schulz, Andrea; Fernandez, Gabriela; Boye, Kristina S.
Affiliation
  • Gelhorn HL; Patient-Centered Research, Evidera, Inc., Bethesda, MD, USA.
  • Osumili B; Value, Evidence, and Outcomes, Eli Lilly and Company, Indianapolis, IN, USA.
  • Brown K; Value, Evidence, and Outcomes, Eli Lilly and Company, Indianapolis, IN, USA.
  • Ross MM; Patient-Centered Research, Evidera, Inc., Bethesda, MD, USA.
  • Schulz A; Patient-Centered Research, Evidera, Inc., Bethesda, MD, USA.
  • Fernandez G; Patient-Centered Research, Evidera, Inc., Bethesda, MD, USA.
  • Boye KS; Value, Evidence, and Outcomes, Eli Lilly and Company, Indianapolis, IN, USA.
Patient Prefer Adherence ; 17: 793-805, 2023.
Article in En | MEDLINE | ID: mdl-36987498
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Prognostic_studies Aspects: Patient_preference Language: En Journal: Patient Prefer Adherence Year: 2023 Document type: Article Affiliation country: Estados Unidos Country of publication: Nueva Zelanda
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Prognostic_studies Aspects: Patient_preference Language: En Journal: Patient Prefer Adherence Year: 2023 Document type: Article Affiliation country: Estados Unidos Country of publication: Nueva Zelanda